Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  12/31/1969
Premier Urology Group
2392
mi
from 98109
New York, NY
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 12/31/1969
Premier Urology Group
2392
mi
from 98109
New York, NY
Click here to add this to my saved trials
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  12/31/1969
Winthrop University
2417
mi
from 98109
Garden City, NY
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 12/31/1969
Winthrop University
2417
mi
from 98109
Garden City, NY
Click here to add this to my saved trials
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Status: Enrolling
Updated:  12/31/1969
University of Rochester
2161
mi
from 98109
Rochester, NY
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention
Status: Enrolling
Updated: 12/31/1969
University of Rochester
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Urology Associates PC
1025
mi
from 98109
Englewood, CO
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Urology Associates PC
1025
mi
from 98109
Englewood, CO
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Houston Metro Urology
1888
mi
from 98109
Houston, TX
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Houston Metro Urology
1888
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Urology Centers of Alabama, PC
2079
mi
from 98109
Birmingham, AL
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Urology Centers of Alabama, PC
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
U.T. Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Royal Melbourne Hospital
8190
mi
from 98109
Melbourne,
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Royal Melbourne Hospital
8190
mi
from 98109
Melbourne,
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
2402
mi
from 98109
New York, NY
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
San Diego Clinical Trials
1063
mi
from 98109
San Diego, CA
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
San Diego Clinical Trials
1063
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Adult and Pediatric Urology P.C
1361
mi
from 98109
Omaha, NE
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Adult and Pediatric Urology P.C
1361
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
2353
mi
from 98109
Albany, NY
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
2353
mi
from 98109
Albany, NY
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Wake Forest School of Medicine
2279
mi
from 98109
Winston-Salem, NC
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Wake Forest School of Medicine
2279
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
University of Vermont College of Medicine
2326
mi
from 98109
Burlington, VT
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
University of Vermont College of Medicine
2326
mi
from 98109
Burlington, VT
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
Virginia Urology
2351
mi
from 98109
Richmond, VA
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
Virginia Urology
2351
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated:  12/31/1969
University of Southern California, Institute of Urology
962
mi
from 98109
Los Angeles, CA
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
A Prospective Multicenter Randomized Blinded Study Comparing Aquablation of the Prostate With the AQUABEAM System and TURP for the Treatment of LUTS
Status: Enrolling
Updated: 12/31/1969
University of Southern California, Institute of Urology
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2117
mi
from 98109
Anniston, AL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2117
mi
from 98109
Anniston, AL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
1065
mi
from 98109
San Diego, CA
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
1065
mi
from 98109
San Diego, CA
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2724
mi
from 98109
Aventura, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2724
mi
from 98109
Aventura, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2511
mi
from 98109
Clearwater, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2511
mi
from 98109
Clearwater, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2511
mi
from 98109
Clearwater, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2511
mi
from 98109
Clearwater, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2731
mi
from 98109
Coral Gables, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2731
mi
from 98109
Coral Gables, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2527
mi
from 98109
Deland, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2527
mi
from 98109
Deland, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2724
mi
from 98109
Hialeah, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2724
mi
from 98109
Hialeah, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2483
mi
from 98109
Ocala, FL
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2483
mi
from 98109
Ocala, FL
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
1857
mi
from 98109
Avon, IN
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
1857
mi
from 98109
Avon, IN
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
1435
mi
from 98109
Wichita, KA
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
1435
mi
from 98109
Wichita, KA
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2326
mi
from 98109
Greenbelt, MD
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2326
mi
from 98109
Greenbelt, MD
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
1366
mi
from 98109
Omaha, NE
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
1366
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2397
mi
from 98109
Englewood, NJ
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2397
mi
from 98109
Englewood, NJ
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
1184
mi
from 98109
Albuquerque, NM
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
1184
mi
from 98109
Albuquerque, NM
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2418
mi
from 98109
Garden City, NY
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2418
mi
from 98109
Garden City, NY
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2402
mi
from 98109
New York, NY
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2376
mi
from 98109
Newburgh, NY
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2376
mi
from 98109
Newburgh, NY
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2374
mi
from 98109
Poughkeepsie, NY
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2374
mi
from 98109
Poughkeepsie, NY
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2286
mi
from 98109
Concord, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2286
mi
from 98109
Concord, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2291
mi
from 98109
High Point, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2291
mi
from 98109
High Point, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2362
mi
from 98109
Raleigh, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2362
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2455
mi
from 98109
Wilmington, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2455
mi
from 98109
Wilmington, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2275
mi
from 98109
Winston-Salem, NC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2275
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2041
mi
from 98109
Akron, OH
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2041
mi
from 98109
Akron, OH
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2487
mi
from 98109
Warwick, RI
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2487
mi
from 98109
Warwick, RI
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2423
mi
from 98109
Charleston, SC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2423
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2229
mi
from 98109
Greer, SC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2229
mi
from 98109
Greer, SC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
2426
mi
from 98109
Mount Pleasant, SC
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
2426
mi
from 98109
Mount Pleasant, SC
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
1890
mi
from 98109
Houston, TX
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
1787
mi
from 98109
San Antonio, TX
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
676
mi
from 98109
Clinton, UT
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
676
mi
from 98109
Clinton, UT
Click here to add this to my saved trials
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated:  12/31/1969
Vantia Investigative Center
675
mi
from 98109
Ogden, UT
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
A Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (BPH) (EQUINOC Study)
Status: Enrolling
Updated: 12/31/1969
Vantia Investigative Center
675
mi
from 98109
Ogden, UT
Click here to add this to my saved trials